Pfizer Inc. buy Guggenheim
Start price
10.02.25
/
50%
€25.02
Target price
10.02.26
€31.98
Performance (%)
-11.07%
Price
27.11.25
€22.25
Summary
This prediction is currently active. The prediction for Pfizer Inc. disappoints with a performance of -11.07%. This prediction currently runs until 10.02.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pfizer Inc. | 5.027% | 5.027% |
| iShares Core DAX® | 3.608% | -2.170% |
| iShares Nasdaq 100 | 4.362% | -1.854% |
| iShares Nikkei 225® | 3.371% | -2.409% |
| iShares S&P 500 | 3.596% | -0.427% |
Comments by Guggenheim for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $33.00 price target on the stock.
Ratings data for PFE provided by MarketBeat